Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 208

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 208
---
|
| General and administrative:                                 |     |              |         |     |   |         |
| RSU awards                                                  |     | $            |  97,077 |     | $ |  89,533 |
| Stock Options                                               |     |              |  58,857 |     |   |  56,204 |
| General and administrative stock-based compensation expense |     |              | 155,934 |     |   | 145,737 |
| Research and development:                                   |     |              |         |     |   |         |
| RSU awards                                                  |     |              |   7,759 |     |   |   7,592 |
| Stock Options                                               |     |              |   5,157 |     |   |   2,392 |
| Research and development stock-based compensation expense   |     |              |  12,916 |     |   |   9,984 |
| Total stock-based compensation expense                      |     | $            | 168,850 |     | $ | 155,721 |

10. Warrants

Public Warrants

In connection with our initial
public offering, we issued and have outstanding as of December 31, 2024 Public Warrants to purchase an aggregate of shares
of common stock with an exercise price of $ per share which expire on (the “Public Warrants”).
The Public Warrants trade on the Nasdaq Capital Market under the ticker symbol REVBW.

The Company may redeem the
Public Warrants at a price of $ per Public Warrant upon not less than 30 days’ prior written notice of redemption if, and
only if, the reported last sale price of the Company’s common stock equals or exceeds $ per share for any 20 trading
days within a 30-trading day period ending on the third business day prior to the notice of redemption to the Public Warrant
holders; and if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying
the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that
wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

Rollover Warrants

In connection with a private
placement on January 31, 2021, Revelation issued warrants to a placement agent to purchase up to shares of common stock